Summit Financial’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
19,570
-10,430
-35% -$94.7K ﹤0.01% 1423
2026
Q1
$212K Sell
30,000
-14,046
-32% -$99.2K ﹤0.01% 1325
2025
Q4
$218K Sell
44,046
-7,564
-15% -$31.9K ﹤0.01% 1217
2025
Q3
$233K Buy
+51,610
New +$176K ﹤0.01% 1154

Other funds holding DRTS

Summit Financial's DRTS Position: Q2 2026 in Review

Summit Financial reduced its Alpha Tau Medical (DRTS) stake by 35% in Q2 2026, selling an estimated $94.7K and leaving 19,570 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Summit Financial first reported a position in DRTS in Q3 2025 and has held it in 4 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Summit Financial held 19,570 shares of Alpha Tau Medical worth $246K as of Q2 2026.
  • Summit Financial sold 10,430 Alpha Tau Medical shares in Q2 2026, an estimated $94.7K.
  • Alpha Tau Medical made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1423 holding.
  • Summit Financial first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 4 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.